Trials / Completed
CompletedNCT00809523
A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)
A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, controlled clinical trial of inactivated negative ion generation or light-emitting photodiode therapy for Seasonal Affective Disorder (SAD, winter depression), for subjects with a DSM IV diagnosis of Major Depression, with Seasonal Pattern, Winter type, to examine efficacy of treatments for this condition. The trial has a 1 week baseline phase and a 4 week treatment phase.
Detailed description
This is a randomized, controlled clinical trial comparing an inactivated negative ion generation (placebo condition) and light-emitting photodiode therapy (active condition), for Seasonal Affective Disorder (SAD, winter depression), for subjects with a DSM IV diagnosis of Major Depression, with Seasonal Pattern, Winter type, to examine efficacy of treatments for this condition. Exclusion criteria included any other current treatment for SAD, as well as bipolar disorder, type 1, a chronic psychotic disorder, or a substance use not if full remission for at least one year. The trial has a 1 week baseline phase and subjects were seen weekly during a 4 week treatment phase. The study was double-blind. The study was conducted at 8 sites in the US, Canada and The Netherlands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Negative Ion Generator | Equivalent exposure to inactivated Negative Ion Generator |
| DEVICE | Light-emitting Photodiode light treatment device | Light-emitting Photodiode light treatment device, used for 30 min before 8 am |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2008-12-17
- Last updated
- 2013-03-06
- Results posted
- 2013-03-06
Locations
8 sites across 3 countries: United States, Canada, Netherlands
Source: ClinicalTrials.gov record NCT00809523. Inclusion in this directory is not an endorsement.